Ascentage Pharma (6855.HK), a prominent global biopharmaceutical firm, recently unveiled the latest preclinical study results for its innovative drug candidates at the American Association of Cancer Research Annual Meeting (AACR 2024) held in San Diego, California. This pivotal revelation underscores the company’s continued dedication to pioneering novel therapies for cancer, chronic hepatitis B (CHB), and […]
In a landmark move within the biotechnology sector, Genmab A/S (Nasdaq: GMAB) and ProfoundBio, Inc. have announced a definitive agreement under which Genmab will acquire ProfoundBio for a staggering USD 1.8 billion in cash. This all-cash transaction underscores Genmab’s strategic intent to broaden its clinical pipeline and enhance its technological capabilities in the fight against […]
Bristol Myers Squibb (NYSE: BMY) has reached a pivotal milestone in the treatment of non-small cell lung cancer (NSCLC) with its announcement regarding the KRYSTAL-12 study’s success. The study focused on evaluating KRAZATI (adagrasib) as a monotherapy for patients with pretreated locally advanced or metastatic NSCLC harboring a KRASG12C mutation. KRAZATI met the primary endpoint […]
Kate Middleton, the Princess of Wales, has publicly disclosed her ongoing preventative chemotherapy treatment after a major abdominal surgery in January unveiled the presence of cancer. This announcement marks a significant health challenge for the British royal family, as King Charles, her father-in-law, is concurrently undergoing cancer treatment. The news of Kate’s health condition has […]
In a strategic move to revolutionize cancer treatment, AstraZeneca has announced its definitive agreement to acquire Fusion Pharmaceuticals Inc., a pioneer in the development of next-generation radioconjugates (RCs) for cancer therapy. This acquisition is a pivotal step for AstraZeneca in fulfilling its vision to transform cancer care, aiming to substitute conventional treatments such as chemotherapy […]
In a notable advancement in the oncology sector, BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a globally recognized oncology company, has received approval from the U.S. Food and Drug Administration (FDA) for TEVIMBRA (tislelizumab-jsgr). This approval marks a significant milestone for TEVIMBRA as a monotherapy in the treatment of adult patients with unresectable or […]
GE HealthCare, a prominent global player in the medical technology and diagnostics sector, is broadening its partnership with Elekta, a leading name in radiation therapy, in India. This collaboration aims to expand accessibility to precision radiation therapy solutions, offering hospitals a comprehensive package for cancer patient diagnostics and treatment requiring radiation therapy. As an integral […]
Yashoda Hospital, in partnership with Elekta, a Swedish developer of precision radiation therapy, has introduced the latter’s Unity MR Linac system in India, marking a significant leap forward in cancer treatment. The advanced technology, which combines the precision of magnetic resonance imaging (MRI) with accurate radiation delivery, sets a new standard for radiation therapy. With […]
Massive Bio, a healthcare technology company specializing in personalized treatment solutions for cancer patients, has announced a non-exclusive partnership with The Oncology Institute (TOI), a leading provider of cutting-edge cancer care. This strategic alliance aims to redefine the landscape of cancer treatment by harnessing advanced artificial intelligence (AI) technology and establishing an extensive nationwide network. […]
Lupin, an Indian pharmaceutical company, has announced a strategic collaboration with Enzene Biosciences, a subsidiary of Alkem Laboratories, to introduce Cetuximab in India. Cetuximab is the first biosimilar developed for Eli Lilly and Company’s Cetuximab, a monoclonal antibody medication used in the treatment of various types of cancer, including head and neck cancer and metastatic […]